» Articles » PMID: 18359394

Bone Disease and Idiopathic Hypercalciuria

Overview
Journal Semin Nephrol
Specialty Nephrology
Date 2008 Mar 25
PMID 18359394
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Observational and epidemiologic studies alike have shown that idiopathic hypercalciuric (IH) stone-forming patients typically show bone mineral density scores that are significantly lower than those observed for age- and sex-matched normal subjects or those for nonhypercalciuric stone-forming patients. Most of these studies have relied on changes in bone mineral density and have not explored the mechanism(s) involved. There have been a small number of studies that have relied on dynamic bone histomorphometry to ascertain the nature of the bone defect in IH patients. When performed, these studies clearly have shown increased bone resorption and high bone turnover in patients with fasting hypercalciuria whereas suppressed bone formation indices are the most consistent finding in patients with the absorptive variant of IH. The causes of this apparent difference in bone remodeling between the 2 variants of IH still is uncertain. Available evidence suggests that potential mechanisms may be dependent in large part to genetic, metabolic, and nutritional causes of hypercalciuria and bone loss in patients with IH.

Citing Articles

Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship.

Messa P, Castellano G, Vettoretti S, Alfieri C, Giannese D, Panichi V Nutrients. 2023; 15(7).

PMID: 37049567 PMC: 10096570. DOI: 10.3390/nu15071724.


Morbidity Associated with Chronic Hyponatremia.

Decaux G J Clin Med. 2023; 12(3).

PMID: 36769626 PMC: 9917626. DOI: 10.3390/jcm12030978.


The Urine Calcium/Creatinine Ratio and Uricemia during Hyponatremia of Different Origins: Clinical Implications.

Decaux G, Musch W J Clin Med. 2023; 12(2).

PMID: 36675652 PMC: 9863532. DOI: 10.3390/jcm12020723.


Idiopathic osteoporosis, Ehlers-Danlos syndrome, postural orthostatic tachycardia syndrome, and mast cell activation disorder in a 27-year-old male patient: A unique case presentation.

Rattray C Clin Case Rep. 2022; 10(5):e05887.

PMID: 35600027 PMC: 9122800. DOI: 10.1002/ccr3.5887.


LIFESTYLE RISK FACTORS AND BONE MASS IN RECURRENT STONE-FORMING PATIENTS: A CROSS-SECTIONAL STUDY IN 144 SUBJECTS.

Maric I, Kizivat T, Smolic M, Smolic R, Opacak-Bernardi T, Solic K Acta Clin Croat. 2020; 58(3):439-445.

PMID: 31969755 PMC: 6971805. DOI: 10.20471/acc.2019.58.03.06.


References
1.
Malluche H, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry S . Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab. 1980; 50(4):654-8. DOI: 10.1210/jcem-50-4-654. View

2.
Heilberg I, Martini L, Szejnfeld V, Carvalho A, Draibe S, AJZEN H . Bone disease in calcium stone forming patients. Clin Nephrol. 1994; 42(3):175-82. View

3.
Garnero P, Delmas P . Biochemical markers of bone turnover. Applications for osteoporosis. Endocrinol Metab Clin North Am. 1998; 27(2):303-23. DOI: 10.1016/s0889-8529(05)70007-4. View

4.
Broadus A, Erickson S, Gertner J, Cooper K, DOBBINS J . An experimental human model of 1,25-dihydroxyvitamin D-mediated hypercalciuria. J Clin Endocrinol Metab. 1984; 59(2):202-6. DOI: 10.1210/jcem-59-2-202. View

5.
Fall P, Breault D, Raisz L . Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblastic cell line Py1a: structure-activity relations and signal transduction mechanisms. J Bone Miner Res. 1994; 9(12):1935-43. DOI: 10.1002/jbmr.5650091213. View